Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 2476842, 8 pages
http://dx.doi.org/10.1155/2016/2476842
Research Article

PTEN Inhibits Cell Proliferation, Promotes Cell Apoptosis, and Induces Cell Cycle Arrest via Downregulating the PI3K/AKT/hTERT Pathway in Lung Adenocarcinoma A549 Cells

1Department of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China
2Department of Respiratory Medicine, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China

Received 27 June 2016; Revised 12 September 2016; Accepted 20 September 2016

Academic Editor: Manoor Prakash Hande

Copyright © 2016 Xiao-Xiao Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-B. Li, Y. Yang, H.-Q. Zhang et al., “High levels of phosphatase and tensin homolog expression predict favorable prognosis in patients with non-small cell lung cancer,” European Review for Medical and Pharmacological Sciences, vol. 19, no. 12, pp. 2231–2239, 2015. View at Google Scholar · View at Scopus
  2. E. J. Kim, S. Y. Lee, T. R. Kim et al., “TSPYL5 is involved in cell growth and the resistance to radiation in A549 cells via the regulation of p21WAF1/Cip1 and PTEN/AKT pathway,” Biochemical and Biophysical Research Communications, vol. 392, no. 3, pp. 448–453, 2010. View at Publisher · View at Google Scholar
  3. L. Wang, L.-E. Wang, L. Mao, M. R. Spitz, and Q. Wei, “A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer,” Clinical Cancer Research, vol. 16, no. 14, pp. 3779–3785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Stražišar, V. Mlakar, and D. Glavač, “The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC),” Cellular and Molecular Biology Letters, vol. 14, no. 3, pp. 442–456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Li, C. Yen, D. Liaw et al., “PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer,” Science, vol. 275, no. 5308, pp. 1943–1947, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. G. L. Mutter, “Commentary—PTEN, a protean tumor suppressor,” The American Journal of Pathology, vol. 158, no. 6, pp. 1895–1898, 2001. View at Google Scholar
  7. Z.-Y. Cheng, X.-L. Guo, S.-H. Li et al., “The role of PTEN-FAK signaling pathway in metastasis and invasive ability of leukemia cells,” Zhonghua Xue Ye Xue Za Zhi, vol. 30, no. 2, pp. 115–120, 2009. View at Google Scholar · View at Scopus
  8. S. Bouali, A.-S. Chrétien, C. Ramacci, M. Rouyer, P. Becuwe, and J.-L. Merlin, “PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells,” Oncology Reports, vol. 21, no. 3, pp. 731–735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Q.-B. She, D. B. Solit, Q. Ye, K. E. O'Reilly, J. Lobo, and N. Rosen, “The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells,” Cancer Cell, vol. 8, no. 4, pp. 287–297, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Gao, F. Ye, X. Xia et al., “Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 29, no. 1, pp. 59–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Ding, B. Ningand, W. Gong et al., “Cyclin D1 induction by benzo[a]pyrene-7,8-diol-9,10-epoxide via the phosphatidylinositol 3-kinase/Akt/MAPK- and p70s6k-dependent pathway promotes cell transformation and tumorigenesis,” The Journal of Biological Chemistry, vol. 284, no. 48, pp. 33311–33319, 2009. View at Publisher · View at Google Scholar
  12. M. Tamura, J. Gu, K. Matsumoto, S.-I. Aota, R. Parsons, and K. M. Yamada, “Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN,” Science, vol. 280, no. 5369, pp. 1614–1617, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kimura, M. Ohmichi, J. Kawagoe et al., “Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines,” Oncogene, vol. 23, no. 26, pp. 4505–4515, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Li, Y. Ni, Z. Tu, S. Wu, Z. Wu, and S. Zheng, “Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance,” European Journal of Cardio-Thoracic Surgery, vol. 36, no. 3, pp. 460–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. C. F. Sealey, L. Zheng, M. A. S. Taboski, Jennifer Cruickshank, M. Ikura, and L. A. Harrington, “The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization,” Nucleic Acids Research, vol. 38, no. 6, pp. 2019–2035, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Zhou, H. Zhu, and J. Lu, “PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma,” Pathology Research and Practice, vol. 211, no. 4, pp. 316–319, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. X.-X. Tian, J. C. S. Pang, S. S. T. To, and H.-K. Ng, “Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 5, pp. 472–479, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. T. Sitaram, C. J. Cairney, P. Grabowski et al., “The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma,” International Journal of Cancer, vol. 125, no. 4, pp. 783–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. L.-F. Min, L.-L. He, C. Qiong, Y. Qiao, and M.-X. Xie, “Magnetic iron oxide nanoparticles carrying PTEN gene to reverse cisplatin-resistance of A549/CDDP cell lines,” Journal of Central South University of Technology, vol. 19, no. 2, pp. 331–339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Chen, H. Bi, J. Hou et al., “Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells,” Cell Death and Disease, vol. 4, no. 9, article e814, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-K. Yoon, H.-P. Kim, S.-W. Han et al., “KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach,” Molecular Carcinogenesis, vol. 49, no. 4, pp. 353–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. F. B. Furnari, H. Lin, H.-J. S. Huang, and W. K. Cavenee, “Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 23, pp. 12479–12484, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Davies, D. Koul, H. Dhesi et al., “Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN,” Cancer Research, vol. 59, no. 11, pp. 2551–2556, 1999. View at Google Scholar · View at Scopus
  24. L.-P. Weng, J. L. Brown, and C. Eng, “PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways,” Human Molecular Genetics, vol. 10, no. 3, pp. 237–242, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Di Cristofano and P. P. Pandolfi, “The multiple roles of PTEN in tumor suppression,” Cell, vol. 100, no. 4, pp. 387–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. L.-P. Weng, O. Gimm, J. B. Kum et al., “Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death,” Human Molecular Genetics, vol. 10, no. 3, pp. 251–258, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. L.-P. Weng, W. M. Smith, P. L. M. Dahia et al., “Pten suppresses breast cancer cell growth by phosphatase activity- dependent arrest followed by cell death,” Cancer Research, vol. 59, no. 22, pp. 5808–5814, 1999. View at Google Scholar · View at Scopus
  28. L. Song, D. Li, Y. Gu et al., “MicroRNA-126 targeting PIK3R2 inhibits NSCLC A549 cell proliferation, migration, and invasion by regulation of PTEN/PI3K/AKT pathway,” Clinical Lung Cancer, vol. 17, no. 5, pp. e65–e75, 2016. View at Publisher · View at Google Scholar
  29. C.-L. Chen, T.-H. Chiang, P.-C. Tseng, Y.-C. Wang, and C.-F. Lin, “Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ,” Biochemical and Biophysical Research Communications, vol. 466, no. 3, pp. 578–584, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Bruni, A. Boccia, G. Baldassarre et al., “PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27(kip1),” Oncogene, vol. 19, no. 28, pp. 3146–3155, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. K. M. Yamada and M. Araki, “Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis,” The Journal of Cell Science, vol. 114, no. 13, pp. 2375–2382, 2001. View at Google Scholar · View at Scopus
  32. H. Wu, S. Wang, D. Weng et al., “Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene,” Cancer Letters, vol. 271, no. 2, pp. 205–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. V. C. H. Wong, J. Ma, and C. E. Hawkins, “Telomerase inhibition induces acute ATM-dependent growth arrest in human astrocytomas,” Cancer Letters, vol. 274, no. 1, pp. 151–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Cong and J. W. Shay, “Actions of human telomerase beyond telomeres,” Cell Research, vol. 18, no. 7, pp. 725–732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Dong, A. Liu, C. Zer et al., “siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells,” BMC Cancer, vol. 9, article 133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. Y.-L. Yang, P.-H. Huang, H.-C. Chiu et al., “Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism,” Biochemical and Biophysical Research Communications, vol. 435, no. 1, pp. 107–112, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Cappuzzo, E. Magrini, G. L. Ceresoli et al., “Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer,” Journal of the National Cancer Institute, vol. 96, no. 15, pp. 1133–1141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Persad, S. Attwell, V. Gray et al., “Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3207–3212, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Huang, J. C. Cheville, Y. Q. Pan, P. C. Roche, L. J. Schmidt, and D. J. Tindall, “PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression,” The Journal of Biological Chemistry, vol. 276, no. 42, pp. 38830–38836, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Li, F. Liu, R. A. Salmonsen et al., “PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation,” Molecular and Cellular Neuroscience, vol. 20, no. 1, pp. 21–29, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. M. H. Cardone, N. Roy, H. R. Stennicke et al., “Regulation of cell death protease caspase-9 by phosphorylation,” Science, vol. 282, no. 5392, pp. 1318–1321, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Wu, V. Goel, and F. G. Haluska, “PTEN signaling pathways in melanoma,” Oncogene, vol. 22, no. 20, pp. 3113–3122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. A. R. Gottschalk, D. Basila, M. Wong et al., “p27Kip1 is required for PTEN-induced G1 growth arrest,” Cancer Research, vol. 61, no. 5, pp. 2105–2111, 2001. View at Google Scholar
  44. H.-J. An, Y.-H. Lee, N.-H. Cho et al., “Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27,” Histopathology, vol. 41, no. 5, pp. 437–445, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. X.-X. Yu, Y.-A. Shi, L.-H. Zhang, Y.-S. Wang, and S. Wu, “Telomerase activity, PI3K/AKT signaling pathway and cellular biological behavior in HeLa cell line,” Chinese Journal of Pathology, vol. 37, no. 5, pp. 323–327, 2008. View at Google Scholar · View at Scopus
  46. C. Zhou, V. L. Bae-Jump, Y. E. Whang, P. A. Gehrig, and J. F. Boggess, “The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels,” Gynecologic Oncology, vol. 101, no. 2, pp. 305–310, 2006. View at Publisher · View at Google Scholar · View at Scopus